Physician profile
Christopher Rush
NPI 1023058351
$1,680.55
in general payments reported to CMS, 2019-2025
13 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $183 · 2021: $15.60 · 2023: $578 · 2024: $469 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,209.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $605.19 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $470.92 | 2020-2024 | Embold Fibered |
| Btg International INC. | $141.79 | 2019 | |
| Philips North America LLC | $111.18 | 2025 | Azurion 7 M20 |
| Penumbra, INC. | $78.74 | 2023-2024 | Indigo System |
| Ge Healthcare | $73.98 | 2019 | |
| Stryker Corporation | $52.08 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Medtronic Vascular, INC. | $44.35 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $26.95 | 2019 | |
| Cardiva Medical, INC. | $26.47 | 2020 | |
| Merit Medical Systems INC | $16.90 | 2024 | One-Step Centesis Catheter, Convertx |
| Bard Peripheral Vascular, INC. | $16.40 | 2024 | |
| Medtronic, INC. | $15.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Rush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.